Loading organizations...
Loading organizations...

Commure: AI-native platform automating healthcare revenue cycle management for providers and health systems, integrating AI and clinical intelligence.
Commure has raised $700.0M across 2 funding rounds.
Key people at Commure.
Commure was founded in 2016 by Deepika Bodapati (Founder) and Tanay Tandon (Founder).
Commure has raised $700.0M in total across 2 funding rounds.
Based in Mountain View, California, Commure develops an AI-native software platform that automates revenue cycle management and clinical workflows for healthcare providers. The company's technology integrates with more than 60 electronic health record systems to process over $25 billion in annual claims and power more than 40 million ambient appointments. Operating at a multibillion-dollar valuation, the enterprise serves over 150 health systems across 2,000 care sites. Commure is backed by venture capital firm General Catalyst and provides its automation tools to major medical networks including NYC Health + Hospitals. The organization has expanded its technological capabilities through strategic acquisitions of healthcare software companies such as Augmedix, PatientKeeper, and Strongline. The current iteration of the business was formed through a 2023 merger with Athelas, a healthcare technology startup originally founded by Tanay Tandon, Deepika Bodapati, and Dhruv Parthasarathy.
---
Commure (formerly Athelas) is an AI-powered healthcare operating system that connects clinical and financial workflows, enabling providers to deliver higher-quality care with greater efficiency. The company builds unified, interoperable platforms that integrate disparate data sources—such as EHRs, billing systems, and patient engagement tools—into a single, intelligent ecosystem. Commure’s solutions serve health systems, hospitals, and private practices, automating everything from clinical documentation and patient intake to revenue cycle management and care coordination.
Commure’s products solve the persistent problem of fragmented healthcare IT, where siloed systems create administrative burdens, increase clinician burnout, and reduce operational efficiency. By leveraging AI-driven automation—both as “copilots” (assisting clinicians) and “autopilots” (fully automating workflows)—Commure streamlines care delivery, accelerates documentation, reduces billing errors, and improves patient outcomes. The company has seen rapid adoption across leading health systems, with measurable improvements in clinician satisfaction, documentation speed, and financial performance.
---
Commure was founded by Tanay Tandon, who previously co-founded Athelas, a company focused on remote patient monitoring and AI-driven diagnostics. The vision for Commure emerged from Tandon’s firsthand experience with the inefficiencies and fragmentation in healthcare IT. Recognizing that most providers were juggling multiple disconnected systems, he set out to build a unified operating system that could connect data, automate workflows, and empower clinicians with intelligent tools.
The company began by developing hardware and telehealth solutions, but quickly pivoted toward software integration and workflow automation as the demand for interoperability and AI-driven efficiency grew. Early traction came from partnerships with large hospital systems and private practices, where Commure’s platform demonstrated tangible improvements in both clinical and financial workflows. The rebrand from Athelas to Commure marked a strategic shift toward becoming a foundational operating system for healthcare, rather than a point solution.
---
---
Commure is riding the wave of AI-driven healthcare transformation, where the convergence of large language models, workflow automation, and interoperability is reshaping how care is delivered. The timing is critical: as healthcare systems face mounting pressure to reduce costs, improve outcomes, and address clinician burnout, the demand for unified, intelligent platforms is accelerating.
Market forces—such as the rise of value-based care, increased regulatory scrutiny, and the need for scalable telehealth solutions—are all working in Commure’s favor. The company is not just a vendor but a catalyst for broader ecosystem change, enabling health systems to move from fragmented, manual processes to integrated, automated workflows. By setting a new standard for AI in healthcare, Commure is influencing how startups, providers, and payers think about interoperability, automation, and patient-centered care.
---
Commure is poised to become the backbone of next-generation healthcare delivery, as more organizations seek to unify their digital infrastructure and harness the power of AI. The company’s dual-mode approach—combining copilots for clinical support and autopilots for administrative automation—positions it at the forefront of the industry’s evolution.
Looking ahead, Commure will likely expand its platform to include more advanced analytics, predictive care coordination, and deeper integration with payer and population health systems. As AI adoption accelerates and regulatory frameworks mature, Commure’s emphasis on ethics, customization, and real-world impact will be key differentiators. The company’s journey reflects a broader shift: from isolated point solutions to integrated, intelligent operating systems that empower providers to focus on what matters most—patients.
Commure’s story is more than a product launch; it’s the foundation for a future-ready healthcare ecosystem, where technology works seamlessly in the background, letting clinicians and patients thrive.
Key people at Commure.
Commure was founded in 2016 by Deepika Bodapati (Founder) and Tanay Tandon (Founder).
Commure has raised $700.0M in total across 2 funding rounds.
Commure's investors include Atomico, Cedar Capital Group, Creandum, CRV, General Catalyst, KFund, Point Nine Capital, Greenoaks Capital, Armaan Ali.
Commure has raised $700.0M across 2 funding rounds. Most recently, it raised $200.0M Series E in June 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 1, 2025 | $200.0M Series E | Atomico, Cedar Capital Group, Creandum, CRV, General Catalyst, KFund, Point Nine Capital | |
| Sep 16, 2021 | $500.0M Series D | Greenoaks Capital, Armaan Ali |